Cocaine impairs ovarian response to exogenous gonadotropins in nonhuman primates

Angela C. Thyer, Thomas S King, Arturo C. Moreno, Carlton A. Eddy, Theresa M. Siler-Khodr, Robert S Schenken

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objective: Determine whether cocaine directly impairs ovarian steroid production and ovulation. Methods: Normally cycling adult female rhesus monkeys received daily intravenous normal saline (control; n = 8) or cocaine (4 mg/kg; n = 8) through the follicular phase. Monkeys were injected daily with human menopausal gonadotropin (hMG; Pergonal) at a dose of 6 IU/kg intramuscularly beginning on cycle day 2. Daily blood samples were obtained, and serum estradiol (E2) and progesterone (P4) were measured by radioimmunoassay. When serum levels of E2 declined, plateaued, or exceeded 600 pg/mL, laparoscopy was performed to count the number of follicles. If no new corpus luteum was present, monkeys were injected intramuscularly with 1000 IU of hCG. Laparoscopy was repeated 2 days later to document the number of ovulatory stigma. Results: During ovarian stimulation, cocaine-treated monkeys required an average additional 1.5 days of hMG injections (P = .01), and this resulted in a greater total dose of hMG compared with control monkeys (351 ± 16 IU versus 297 ± 15 IU [mean ± standard error of the mean], P = .03). For spontaneous and hCG-triggered ovulation, the number of ovulatory stigma was significantly lower (P < .003) in the cocaine-treated versus control monkeys (16 versus 31). Peak E2 levels were significantly (P = .05) lower in cocaine-treated monkeys compared with controls. Luteal phase P4 levels were lower in the cocaine-treated monkeys, but the difference was not statistically significant when compared with controls. Conclusion: Cocaine impaired ovarian responsiveness to exogenous gonadotropins and decreased ovulatory stigma in nonhuman primates. These findings suggest that cocaine has direct ovarian effects.

Original languageEnglish (US)
Pages (from-to)358-362
Number of pages5
JournalJournal of the Society for Gynecologic Investigation
Volume8
Issue number6
DOIs
StatePublished - 2001

Fingerprint

Gonadotropins
Cocaine
Primates
Haplorhini
Menotropins
Ovulation
Laparoscopy
Follicular Phase
Ovulation Induction
Luteal Phase
Corpus Luteum
Macaca mulatta
Serum
Radioimmunoassay
Progesterone
Estradiol
Steroids
Injections

Keywords

  • Cocaine
  • Gonadotropins
  • Ovary

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Cocaine impairs ovarian response to exogenous gonadotropins in nonhuman primates. / Thyer, Angela C.; King, Thomas S; Moreno, Arturo C.; Eddy, Carlton A.; Siler-Khodr, Theresa M.; Schenken, Robert S.

In: Journal of the Society for Gynecologic Investigation, Vol. 8, No. 6, 2001, p. 358-362.

Research output: Contribution to journalArticle

Thyer, Angela C. ; King, Thomas S ; Moreno, Arturo C. ; Eddy, Carlton A. ; Siler-Khodr, Theresa M. ; Schenken, Robert S. / Cocaine impairs ovarian response to exogenous gonadotropins in nonhuman primates. In: Journal of the Society for Gynecologic Investigation. 2001 ; Vol. 8, No. 6. pp. 358-362.
@article{1f6cde95da4041e5a22a86c4e242d444,
title = "Cocaine impairs ovarian response to exogenous gonadotropins in nonhuman primates",
abstract = "Objective: Determine whether cocaine directly impairs ovarian steroid production and ovulation. Methods: Normally cycling adult female rhesus monkeys received daily intravenous normal saline (control; n = 8) or cocaine (4 mg/kg; n = 8) through the follicular phase. Monkeys were injected daily with human menopausal gonadotropin (hMG; Pergonal) at a dose of 6 IU/kg intramuscularly beginning on cycle day 2. Daily blood samples were obtained, and serum estradiol (E2) and progesterone (P4) were measured by radioimmunoassay. When serum levels of E2 declined, plateaued, or exceeded 600 pg/mL, laparoscopy was performed to count the number of follicles. If no new corpus luteum was present, monkeys were injected intramuscularly with 1000 IU of hCG. Laparoscopy was repeated 2 days later to document the number of ovulatory stigma. Results: During ovarian stimulation, cocaine-treated monkeys required an average additional 1.5 days of hMG injections (P = .01), and this resulted in a greater total dose of hMG compared with control monkeys (351 ± 16 IU versus 297 ± 15 IU [mean ± standard error of the mean], P = .03). For spontaneous and hCG-triggered ovulation, the number of ovulatory stigma was significantly lower (P < .003) in the cocaine-treated versus control monkeys (16 versus 31). Peak E2 levels were significantly (P = .05) lower in cocaine-treated monkeys compared with controls. Luteal phase P4 levels were lower in the cocaine-treated monkeys, but the difference was not statistically significant when compared with controls. Conclusion: Cocaine impaired ovarian responsiveness to exogenous gonadotropins and decreased ovulatory stigma in nonhuman primates. These findings suggest that cocaine has direct ovarian effects.",
keywords = "Cocaine, Gonadotropins, Ovary",
author = "Thyer, {Angela C.} and King, {Thomas S} and Moreno, {Arturo C.} and Eddy, {Carlton A.} and Siler-Khodr, {Theresa M.} and Schenken, {Robert S}",
year = "2001",
doi = "10.1016/S1071-5576(01)00133-2",
language = "English (US)",
volume = "8",
pages = "358--362",
journal = "Reproductive Sciences",
issn = "1933-7191",
publisher = "SAGE Publications Inc.",
number = "6",

}

TY - JOUR

T1 - Cocaine impairs ovarian response to exogenous gonadotropins in nonhuman primates

AU - Thyer, Angela C.

AU - King, Thomas S

AU - Moreno, Arturo C.

AU - Eddy, Carlton A.

AU - Siler-Khodr, Theresa M.

AU - Schenken, Robert S

PY - 2001

Y1 - 2001

N2 - Objective: Determine whether cocaine directly impairs ovarian steroid production and ovulation. Methods: Normally cycling adult female rhesus monkeys received daily intravenous normal saline (control; n = 8) or cocaine (4 mg/kg; n = 8) through the follicular phase. Monkeys were injected daily with human menopausal gonadotropin (hMG; Pergonal) at a dose of 6 IU/kg intramuscularly beginning on cycle day 2. Daily blood samples were obtained, and serum estradiol (E2) and progesterone (P4) were measured by radioimmunoassay. When serum levels of E2 declined, plateaued, or exceeded 600 pg/mL, laparoscopy was performed to count the number of follicles. If no new corpus luteum was present, monkeys were injected intramuscularly with 1000 IU of hCG. Laparoscopy was repeated 2 days later to document the number of ovulatory stigma. Results: During ovarian stimulation, cocaine-treated monkeys required an average additional 1.5 days of hMG injections (P = .01), and this resulted in a greater total dose of hMG compared with control monkeys (351 ± 16 IU versus 297 ± 15 IU [mean ± standard error of the mean], P = .03). For spontaneous and hCG-triggered ovulation, the number of ovulatory stigma was significantly lower (P < .003) in the cocaine-treated versus control monkeys (16 versus 31). Peak E2 levels were significantly (P = .05) lower in cocaine-treated monkeys compared with controls. Luteal phase P4 levels were lower in the cocaine-treated monkeys, but the difference was not statistically significant when compared with controls. Conclusion: Cocaine impaired ovarian responsiveness to exogenous gonadotropins and decreased ovulatory stigma in nonhuman primates. These findings suggest that cocaine has direct ovarian effects.

AB - Objective: Determine whether cocaine directly impairs ovarian steroid production and ovulation. Methods: Normally cycling adult female rhesus monkeys received daily intravenous normal saline (control; n = 8) or cocaine (4 mg/kg; n = 8) through the follicular phase. Monkeys were injected daily with human menopausal gonadotropin (hMG; Pergonal) at a dose of 6 IU/kg intramuscularly beginning on cycle day 2. Daily blood samples were obtained, and serum estradiol (E2) and progesterone (P4) were measured by radioimmunoassay. When serum levels of E2 declined, plateaued, or exceeded 600 pg/mL, laparoscopy was performed to count the number of follicles. If no new corpus luteum was present, monkeys were injected intramuscularly with 1000 IU of hCG. Laparoscopy was repeated 2 days later to document the number of ovulatory stigma. Results: During ovarian stimulation, cocaine-treated monkeys required an average additional 1.5 days of hMG injections (P = .01), and this resulted in a greater total dose of hMG compared with control monkeys (351 ± 16 IU versus 297 ± 15 IU [mean ± standard error of the mean], P = .03). For spontaneous and hCG-triggered ovulation, the number of ovulatory stigma was significantly lower (P < .003) in the cocaine-treated versus control monkeys (16 versus 31). Peak E2 levels were significantly (P = .05) lower in cocaine-treated monkeys compared with controls. Luteal phase P4 levels were lower in the cocaine-treated monkeys, but the difference was not statistically significant when compared with controls. Conclusion: Cocaine impaired ovarian responsiveness to exogenous gonadotropins and decreased ovulatory stigma in nonhuman primates. These findings suggest that cocaine has direct ovarian effects.

KW - Cocaine

KW - Gonadotropins

KW - Ovary

UR - http://www.scopus.com/inward/record.url?scp=0035678885&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035678885&partnerID=8YFLogxK

U2 - 10.1016/S1071-5576(01)00133-2

DO - 10.1016/S1071-5576(01)00133-2

M3 - Article

C2 - 11750872

AN - SCOPUS:0035678885

VL - 8

SP - 358

EP - 362

JO - Reproductive Sciences

JF - Reproductive Sciences

SN - 1933-7191

IS - 6

ER -